Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Epidemiology
Louisiana HIV Rates Are the Lowest in a Decade

Doctors attribute the drop to increased testing and U=U.

Published
10 July 2019
From
POZ
PrEP policies and guidelines
NHS England recommends uncapped PrEP trial access

NHS England have announced five steps towards better access to the HIV prevention drug PrEP, including recommending removing the capped number of places on the ongoing IMPACT Trial. This follows a meeting yesterday between Simon Stevens, chief executive of NHS England, NAT (National AIDS Trust), Terrence Higgins Trust, and PrEPster.

Published
08 July 2019
From
National Health Executive
Clinical trials
EU Calls For Results Of All EU-based Clinical Trials To Be Added To Public Database

The European Commission and European Union medicines regulatory agencies sent an open letter to all sponsors of EU-based clinical trials to remind them of their obligation to publish the results of the trials – both positive and negative – in a public database.

Published
07 July 2019
From
Health Policy Watch
Global health initiatives
Who should lead UNAIDS?

Richard Horton: Who is best qualified to lead an organisation—UNAIDS— that has not only suffered severe reputational loss, but also faces threats to its continuing existence?

Published
07 July 2019
From
The Lancet
Epidemiology
Russia's HIV Epidemic is Growing, Affecting Older Citizens

HIV infections are on the rise and are increasingly affecting Russia’s older population, according to a consumer watchdog report cited by the RBC news website.

Published
07 July 2019
From
Moscow Times
Government, leadership and policy
Living proof of Hawke and his successors' triumph against HIV

The Bob Hawke government's response to the shock emergence of an alien health crisis is still saving lives after 30 years. There was nothing pre-ordained about this success. Other nations took other approaches. Among the rich countries, the US handling of AIDS notoriously was bungled.

Published
07 July 2019
From
Sydney Morning Herald
Pharmaceutical industry
What Does PrEP Cost Outside the United States?

For the past several years, doctors in the United States have watched enviously as other countries have approved generic versions of PrEP made by Mylan, Teva, and other generic drug companies. These cheaper generics have made it easier for governments to support large PrEP scale-up programs.

Published
04 July 2019
From
The Body
Achieving the 90-90-90 target
WHO’s “Treat All” Policy Had Immediate Effect on Global HIV Treatment Rates

The World Health Organization (WHO) recommendation in 2015 that all nations provide HIV treatment regardless of an individual’s CD4 count had a rapid and stark effect on increasing rates of rapid access to antiretrovirals (ARVs) in various developing nations.

Published
04 July 2019
From
POZ
Pharmaceutical industry
HHS gets a new HIV prevention patent, but will the agency demand royalties from Gilead?

On Tuesday, the Department of Health and Human Services was awarded a new patent that broadly covers medicines derived from tenofovir and used to prevent HIV.

Published
03 July 2019
From
STAT
Epidemiology
HIV diagnoses in Australia drop to lowest number in 18 years

Australia continues to lead the world in HIV prevention and in 2018 recorded the lowest number of HIV diagnoses since 2001. According to a report released today by the Kirby Institute at UNSW Sydney, last year there were 835 HIV diagnoses across the country, which represents a decline of 23% over five years.

Published
03 July 2019
From
University of New South Wales
← Prev12345...566Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.